BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

957 related articles for article (PubMed ID: 11346728)

  • 1. Matrix metalloproteinases in mild and severe temporomandibular joint internal derangement synovial fluid.
    Srinivas R; Sorsa T; Tjäderhane L; Niemi E; Raustia A; Pernu H; Teronen O; Salo T
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 May; 91(5):517-25. PubMed ID: 11346728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids of patients with temporomandibular joint osteoarthritis.
    Kanyama M; Kuboki T; Kojima S; Fujisawa T; Hattori T; Takigawa M; Yamashita A
    J Orofac Pain; 2000; 14(1):20-30. PubMed ID: 11203734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levels of matrix metalloproteinase (MMP)-1 in paired sera and synovial fluids of juvenile idiopathic arthritis patients: relationship to inflammatory activity, MMP-3 and tissue inhibitor of metalloproteinases-1 in a longitudinal study.
    Peake NJ; Khawaja K; Myers A; Jones D; Cawston TE; Rowan AD; Foster HE
    Rheumatology (Oxford); 2005 Nov; 44(11):1383-9. PubMed ID: 16049050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix metalloproteinase and tissue inhibitor of metalloproteinase in serum and lavage synovial fluid of patients with temporomandibular joint disorders.
    Ishimaru JI; Oguma Y; Goss AN
    Br J Oral Maxillofac Surg; 2000 Aug; 38(4):354-9. PubMed ID: 10922168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occurrence of matrix metalloproteinases and tissue inhibitors of metalloproteinases in tuberculous pleuritis.
    Hoheisel G; Sack U; Hui DS; Huse K; Chan KS; Chan KK; Hartwig K; Schuster E; Scholz GH; Schauer J
    Tuberculosis (Edinb); 2001; 81(3):203-9. PubMed ID: 11466032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Porphyromonas gingivalis affects host collagen degradation by affecting expression, activation, and inhibition of matrix metalloproteinases.
    Zhou J; Windsor LJ
    J Periodontal Res; 2006 Feb; 41(1):47-54. PubMed ID: 16409255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of stromelysin-1, 72 and 92 kDa type IV collagenase, tissue inhibitor of metalloproteinase-1 (TIMP-1), and TIMP-2 in synovial fluid and serum from patients with rheumatoid arthritis.
    Ishiguro N; Ito T; Obata K; Fujimoto N; Iwata H
    J Rheumatol; 1996 Sep; 23(9):1599-604. PubMed ID: 8877931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study of metalloproteinases in fifty joint fluid specimens.
    Gaudin P; Razakaboay M; Surla A; Berthier S; Fauconnier J; Morel F; Phelip X
    Rev Rhum Engl Ed; 1997 Jun; 64(6):375-81. PubMed ID: 9513609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MMP profile in paired serum and synovial fluid samples of patients with rheumatoid arthritis.
    Tchetverikov I; Ronday HK; Van El B; Kiers GH; Verzijl N; TeKoppele JM; Huizinga TW; DeGroot J; Hanemaaijer R
    Ann Rheum Dis; 2004 Jul; 63(7):881-3. PubMed ID: 15194590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The matrix metalloproteinase system in oral squamous cell carcinoma.
    Baker EA; Leaper DJ; Hayter JP; Dickenson AJ
    Br J Oral Maxillofac Surg; 2006 Dec; 44(6):482-6. PubMed ID: 16338034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cigarette smoke condensate affects the collagen-degrading ability of human gingival fibroblasts.
    Zhang W; Song F; Windsor LJ
    J Periodontal Res; 2009 Dec; 44(6):704-13. PubMed ID: 19453854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix metalloproteinases and their tissue inhibitors in the lesions of cardiac and pulmonary sarcoidosis: an immunohistochemical study.
    González AA; Segura AM; Horiba K; Qian S; Yu ZX; Stetler-Stevenson W; Willerson JT; McAllister HA; Ferrans VJ
    Hum Pathol; 2002 Dec; 33(12):1158-64. PubMed ID: 12514782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.
    Keyszer G; Lambiri I; Nagel R; Keysser C; Keysser M; Gromnica-Ihle E; Franz J; Burmester GR; Jung K
    J Rheumatol; 1999 Feb; 26(2):251-8. PubMed ID: 9972954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cathepsin C, matrix metalloproteinases, and their tissue inhibitors in gingiva and gingival crevicular fluid from periodontitis-affected patients.
    Soell M; Elkaim R; Tenenbaum H
    J Dent Res; 2002 Mar; 81(3):174-8. PubMed ID: 11876270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of matrix metalloproteinases (MMPs) in synovial fluid from patients with temporomandibular disorder.
    Kubota T; Kubota E; Matsumoto A; Kawai Y; Saito H; Mikuni-Takagaki Y; Sato S
    Eur J Oral Sci; 1998 Dec; 106(6):992-8. PubMed ID: 9879910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of matrix metalloproteinases 2 and 9, tissue inhibitor of metalloproteinases and apoptosis in tissue remodelling in the sheep placenta.
    Riley SC; Webb CJ; Leask R; McCaig FM; Howe DC
    J Reprod Fertil; 2000 Jan; 118(1):19-27. PubMed ID: 10793622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gelatinolytic and collagenolytic activity in periprosthetic tissues from loose hip endoprostheses.
    Syggelos SA; Eleftheriou SC; Giannopoulou E; Panagiotopoulos E; Aletras AJ
    J Rheumatol; 2001 Jun; 28(6):1319-29. PubMed ID: 11409126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effect of matrix metalloproteinase inhibitors against epidermal basement membrane damage: skin equivalents partially mimic photoageing process.
    Amano S; Ogura Y; Akutsu N; Matsunaga Y; Kadoya K; Adachi E; Nishiyama T
    Br J Dermatol; 2005 Dec; 153 Suppl 2():37-46. PubMed ID: 16280020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoactivation profiles of calcium-dependent matrix metalloproteinase-2 and -9 in inflammatory synovial fluid: effect of pyrophosphate and bisphosphonates.
    Makowski GS; Ramsby ML
    Clin Chim Acta; 2005 Aug; 358(1-2):182-91. PubMed ID: 15921672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MMP protein and activity levels in synovial fluid from patients with joint injury, inflammatory arthritis, and osteoarthritis.
    Tchetverikov I; Lohmander LS; Verzijl N; Huizinga TW; TeKoppele JM; Hanemaaijer R; DeGroot J
    Ann Rheum Dis; 2005 May; 64(5):694-8. PubMed ID: 15834054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.